Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
| Line item | Year Ended April 30, 2026 | Year Ended April 30, 2025 |
|---|---|---|
| Other long-term assets | 40 | 40 |
| Net cash used in operating activities | (81,703) | (77,608) |
| Cash flows from investing activities | ||
| Purchases of property and equipment | (34,892) | (22,936) |
| Deposits for medical rental equipment | (528) | (655) |
| Refund of deposits for medical rental equipment | 184 | 283 |
| Investment in equity security | (5,000) | — |
| Purchase of marketable securities | (163,041) | — |
Item 16. Form 10-K Summary.
FAQ
- What is Kestra Medical Technologies's capex?
- Kestra Medical Technologies (KMTS) reported capex of $9.66M in Q1 2026.
- How has Kestra Medical Technologies's capex changed year-over-year?
- Kestra Medical Technologies's capex increased by 30.8% year-over-year, from $7.39M to $9.66M.
- What is the long-term trend for Kestra Medical Technologies's capex?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's capex has grown at a 68.9% compound annual growth rate (CAGR), from $12.23M to $34.89M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Kestra Medical Technologies's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude